Abstract:Aim: The aim of the study was to investigate the factors that underpin neuropsychiatric symptoms and how they might evolve over time in people with Mild Cognitive Impairment (MCI) and Alzheimer’s disease (AD) dementia. Background: Neuropsychiatric symptoms are psychiatric and behavioural manifestations that occur in people with AD. These are highly prevalent along the continuum of the disease, including at the stage of MCI, as well as before cognitive decline. Various small- and large-scale projects have investigated the underlying factors that underpin these symptoms; however, the identification of clear clusters is still a matter of debate; furthermore, no study has investigated how the clusters might change across the development of AD pathology by comparing different time points. Objective: Our objective was to investigate the factors that underpin neuropsychiatric symptoms in Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI) and to assess how the loadings might differ based on considerations such as the disease stage of the samples. Methods: Data was obtained from the Alzheimer’s Disease Neuroimaging Initiative database (adni. loni.usc.edu), using scores from the Neuropsychiatric Inventory, followed up yearly from baseline until month 72. Participant groups included those with MCI or AD dementia, or a mixture of both, with all participants presenting with at least one neuropsychiatric symptom. A series of exploratory Principal Component and Factor (Principal Axis) Analyses were performed using Direct Oblimin rotation. Results: The best-fitting structure was interpreted for each time point. A consistent, unique structure could not be identified, as the factors were unstable over time, both within the MCI and AD groups. However, some symptoms showed a tendency to load on the same factors across most measurements (i.e., agitation with irritability, depression with anxiety, elation with disinhibition, delusions with hallucinations). conclusion: Although the analyses revealed some degree of co-occurrence of neuropsychiatric symptoms across time-points/samples, there was also considerable variation. In the AD group, more discrete syndromes were evident at the early time-points, whereas a more complex picture of co-occurring symptoms, with the differences likely reflecting disease staging, was seen at later time-points. As a clear and distinctive factor structure was not consistently identified across time-points/samples, this highlights the potential importance of sample selection (e.g., disease stage and/or heterogeneity) when studying, for example, neurobiological underpinnings of neuropsychiatric symptoms. Conclusion: Although the analyses revealed some degree of co-occurrence of neuropsychiatric symptoms across time points/samples, there was also considerable variation. In the AD group, more discrete syndromes were evident at the early time points, whereas a more complex picture of co-occurring symptoms, with differences likely reflecting disease staging, was seen at later time points. As a clear and distinctive factor structure was not consistently identified across time points/ samples, this highlights the potential importance of sample selection (e.g., disease stage and/or heterogeneity) when studying, for example, the neurobiological underpinnings of neuropsychiatric symptoms.

Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment

Aggregation of Vascular Risk Factors Modulates the Amplitude of Low-Frequency Fluctuation in Mild Cognitive Impairment Patients

Depression Affects Intrinsic Brain Activity in Patients with Mild Cognitive Impairment.

Prevalence of Neuropsychiatric Symptoms Across the Declining Memory Continuum: an Observational Study in a Memory Clinic Setting

Neuropsychiatric symptoms associated multimodal brain networks in Alzheimer's disease

Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients

Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline

P3-459: Neuropsychiatric Features in Alzheimer's Disease and Mild Cognitive Impairment in Memory Clinic

Effects of Anosognosia on Static and Dynamic Amplitudes of Low-Frequency Fluctuation in Mild Cognitive Impairment

Neurometabolic Characteristics in the Anterior Cingulate Gyrus of Alzheimer’s Disease Patients with Depression: a 1H Magnetic Resonance Spectroscopy Study

Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study

Neuropsychiatric Symptom Profile in Alzheimer's Disease and Their Relationship With Functional Decline

Association Between Amygdala Volume and Trajectories of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia With Lewy Bodies

Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study

Role of fronto-limbic circuit in neuropsychiatric symptoms of dementia: clinical evidence from an exploratory study

Anosognosia is associated with increased prevalence and faster development of neuropsychiatric symptoms in mild cognitive impairment

Neuroanatomical associations of depression, anxiety and apathy neuropsychiatric symptoms in patients with Alzheimer’s disease

Neuropsychiatric symptoms as prognostic makers for the elderly with mild cognitive impairment: a meta-analysis

The neural basis of neuropsychiatric symptoms in Alzheimer's disease

Behavioral and Psychological Symptoms in Alzheimer's Disease.

Assessing the Stability of Clusters of Neuropsychiatric Symptoms in Alzheimer’s Disease and Mild Cognitive Impairment